WILSON GAYLE E

SEC source: 0001127602-20-015829 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,270 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2020.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2020.

SEC source: 0001127602-20-015829 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

SEC source: 0001127602-20-004969 · form4.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,720 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options vesed quarterly over the first year of service and were fully vested on May 11, 2011.

SEC source: 0001127602-20-004969 · form4.xml · nonDerivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,782

F1 · price: Sale prices reported for the transactions reported here range from $67.71 to $67.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

SEC source: 0001127602-20-004969 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-19-018178 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,848

Underlying: Common Stock · 11,848 shares

Expires 2029-05-08

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-19-018178 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,270

Underlying: Common Stock · 2,270 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-19-017785 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,283 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 7, 2019.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 7, 2019.

SEC source: 0001127602-19-017785 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

SEC source: 0001127602-19-007332 · form4.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,068 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 6, 2010.

SEC source: 0001127602-19-007332 · form4.xml · nonDerivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,499

F1 · price: Sale prices reported for the transactions reported here range from $67.07 to $67.10. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

SEC source: 0001127602-19-007332 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,567

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-017244 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,283

Underlying: Common Stock · 2,283 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-18-017244 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,496

Underlying: Common Stock · 9,496 shares

Expires 2028-05-09

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-18-016967 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,241 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 8, 2018.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 8, 2018.

SEC source: 0001127602-18-016967 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

SEC source: 0001127602-18-005574 · form4.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,000 shares

Expires 2018-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Options vest 100% on the first anniversary date of the grant.

SEC source: 0001127602-18-005574 · form4.xml · nonDerivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,258

F1 · price: Sale prices reported for the transactions reported here range from $77.88 to $78.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

SEC source: 0001127602-18-005574 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-17-017987 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-17-017987 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,376

Underlying: Common Stock · 10,376 shares

Expires 2027-05-10

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-17-017798 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,787 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 9, 2017.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 9, 2017.

SEC source: 0001127602-17-017798 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

SEC source: 0001127602-17-008730 · form4.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,350 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Options are 100% vested on the date of grant.

SEC source: 0001127602-17-008730 · form4.xml · nonDerivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,471

F1 · price: Sale prices reported for the transactions reported here range from $69.281 to $69.331. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

SEC source: 0001127602-17-008730 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-16-069217 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,149.6611 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · shares: An aggregate of 2149.6611 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 2.6611 was paid out in cash in connection with the conversion into shares of common stock.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001127602-16-069217 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,486

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

SEC source: 0001127602-16-063778 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,149.6611

Underlying: Common Stock · 12.8985 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001127602-16-056779 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,136.7626

Underlying: Common Stock · 12.1378 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001127602-16-052224 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,321

Underlying: Common Stock · 7,321 shares

Expires 2026-05-11

F3 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-16-052224 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,787

Underlying: Common Stock · 1,787 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001127602-16-051673 · form4.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,466 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2016.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2016.

SEC source: 0001127602-16-051673 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,339

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

SEC source: 0001127602-16-048097 · form4.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,124.6248

Underlying: Common Stock · 9.8873 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001127602-16-043917 · form4.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,350

Underlying: Common Stock · 6,650 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options are 100% vested on the date of grant.

SEC source: 0001127602-16-043917 · form4.xml · nonDerivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,873

SEC source: 0001127602-16-043917 · form4.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-16-016952 · edgar.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,114.7376

Underlying: Common Stock · 8.8638 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001179110-15-015783 · edgar.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,105.8737

Underlying: Common Stock · 2,105.8737 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F3 · shares: An aggregate of 2105.8737 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 1.8737 was paid out in cash in connection with the conversion into shares of common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001179110-15-015783 · edgar.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,873

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

SEC source: 0001179110-15-013510 · edgar.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,211.7476

Underlying: Common Stock · 18.781 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001179110-15-012782 · edgar.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 80,000 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options are 100% vested on the date of grant.

SEC source: 0001179110-15-012782 · edgar.xml · nonDerivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,769

SEC source: 0001179110-15-012782 · edgar.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-15-010622 · edgar.xml · derivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,192.9666

Underlying: Common Stock · 15.5583 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

SEC source: 0001179110-15-007270 · edgar.xml · derivative · entry 4

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,167

Underlying: Common Stock · 5,167 shares

Expires 2025-05-06

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001179110-15-007270 · edgar.xml · derivative · entry 3

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,466

Underlying: Common Stock · 1,466 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

SEC source: 0001179110-15-007270 · edgar.xml · derivative · entry 2

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,904 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2015.

F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2015.

SEC source: 0001179110-15-007270 · edgar.xml · nonDerivative · entry 1

WILSON GAYLE E · CIK 0001198227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.